Exchange: NSE·Updated 04:00 PM GMT+5:30

GENESYS.NSE News

News
all
press releases
Brief Multi-Strategy: APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia and more
In this briefing: APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Will Hybrid-Attendance and Virtual-Only Shareholder Meetings Become More Common? Weekly Deals Digest (12 Apr) - Victory Giant, Huaqin, Manycore, Sigenergy, Global, Olympic, Sankei Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth 1. APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Wuxi XDC partnered with Akari Therapeutics to accelerate IND filing for Akari’s ADC program. Xuanzhu Biopharmaceutical entered licensing agreement with Boston Oncology for upfront and milestone payments of $100M+. Shionogi secured $119M BARDA contract for manufacturing, procurement, and expanded development of Fetroja for biothreat-related infections. ABL Bio’s partner has received Orphan Drug Designation from the FDA for tovecimig. PharmaEssentia signed an investment agreement for a new manufacturing facility in Puerto Rico.
cityfalcon.com
Brief Multi-Strategy: APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia and more
In this briefing: APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Will Hybrid-Attendance and Virtual-Only Shareholder Meetings Become More Common? Weekly Deals Digest (12 Apr) - Victory Giant, Huaqin, Manycore, Sigenergy, Global, Olympic, Sankei Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth 1. APAC Healthcare Weekly (April 12) – Wuxi XDC, Xuanzhu Biopharma, Shionogi, ABL Bio, PharmaEssentia Wuxi XDC partnered with Akari Therapeutics to accelerate IND filing for Akari’s ADC program. Xuanzhu Biopharmaceutical entered licensing agreement with Boston Oncology for upfront and milestone payments of $100M+. Shionogi secured $119M BARDA contract for manufacturing, procurement, and expanded development of Fetroja for biothreat-related infections. ABL Bio’s partner has received Orphan Drug Designation from the FDA for tovecimig. PharmaEssentia signed an investment agreement for a new manufacturing facility in Puerto Rico.
cityfalcon.com
More News
Brief Multi-Strategy: Will Hybrid-Attendance and Virtual-Only Shareholder Meetings Become More Common? and more
In this briefing: Will Hybrid-Attendance and Virtual-Only Shareholder Meetings Become More Common? Weekly Deals Digest (12 Apr) - Victory Giant, Huaqin, Manycore, Sigenergy, Global, Olympic, Sankei Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth Hong Kong Single Stock Options Weekly (Apr 08–10): Markets Awaken on the Back of Midweek Taco Rally 1. Will Hybrid-Attendance and Virtual-Only Shareholder Meetings Become More Common? Most Prime Market-listed companies have adopted electronic voting in accordance with the requirements of the Corporate Governance Code. Electronic voting will increase among companies outside Prime Market going forward. The number of hybrid and virtual-only shareholder meetings—where shareholders are permitted to ask questions and exercise their voting rights in real time online—remains very small and has not increased. This issue is related to the reasons why hybrid-attendance and virtual-only shareholder meetings aren't becoming more common, as well as to the disclosure of annual securities reports prior to AGMs. 2.
cityfalcon.com
Brief Multi-Strategy: Weekly Deals Digest (12 Apr) - Victory Giant, Huaqin, Manycore, Sigenergy, Global, Olympic, Sankei and more
In this briefing: Weekly Deals Digest (12 Apr) - Victory Giant, Huaqin, Manycore, Sigenergy, Global, Olympic, Sankei Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth Hong Kong Single Stock Options Weekly (Apr 08–10): Markets Awaken on the Back of Midweek Taco Rally HEW: Ceasefire Relief Reversal 1. Weekly Deals Digest (12 Apr) - Victory Giant, Huaqin, Manycore, Sigenergy, Global, Olympic, Sankei A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, New Zealand, Singapore, Japan, Indonesia, Malaysia, Thailand, Korea, India and Chinese ADRs. ECM developments: Huaqin Technology (603296 CH) , Manycore Tech (68 HK) , Sigenergy Technology (6656 HK) and Victory Giant Technology -A (300476 CH) HKEx listings. Event-Driven developments: Global Ltd/The (3271 JP) , Olympic Group (8289 JP) , Sankei Real Estate (2972 JP) , Insignia Financial (IFL AU) , National Storage REIT (NSR AU) . 2.
cityfalcon.com
Brief India: Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! and more
In this briefing: Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! Primer: Shaily Engineering Plastics (SHEP IN) - Apr 2026 True Cost of Running an AI Data Centre: A Unit Economics Breakdown Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth 1. Gas Insecurity: India Imports 36 BCM of LNG Annually, Stores Almost None of It! Escalating West Asia tensions and near-closure of the Strait of Hormuz have exposed India's ~10-day LNG buffer, triggering a draft PNGRB policy mandating a 10% buffer at terminals. India imports 36 BCM of LNG annually, the 4th-largest globally, with fertiliser, CGD, and industrial sectors structurally dependent on it, yet holds zero strategic gas reserve. A multi-year capex cycle for above-ground LNG tanks, FSRU-based buffers, and pipeline densification will disproportionately benefit Petronet LNG, HPCL, GAIL, Swan Energy, and Gujarat State Petronet. 2.
cityfalcon.com
Brief India: Primer: Shaily Engineering Plastics (SHEP IN) - Apr 2026 and more
In this briefing: Primer: Shaily Engineering Plastics (SHEP IN) - Apr 2026 True Cost of Running an AI Data Centre: A Unit Economics Breakdown Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth Primer: Nava (NAVA IN) - Apr 2026 1. Primer: Shaily Engineering Plastics (SHEP IN) - Apr 2026 Shaily Engineering Plastics is strategically positioned to capitalize on the high-growth healthcare sector, particularly in the drug delivery devices market, which is expected to drive significant revenue and margin expansion. The company has established long-standing relationships with marquee clients like IKEA, which provides a stable revenue base in its consumer segment, complementing the growth in the more profitable healthcare business. Significant investment in capacity expansion and a focus on intellectual property-led products, such as their proprietary insulin pens, are key pillars of their strategy to move up the value chain and enhance profitability.
cityfalcon.com
Brief Multi-Strategy: Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? and more
In this briefing: Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth Hong Kong Single Stock Options Weekly (Apr 08–10): Markets Awaken on the Back of Midweek Taco Rally HEW: Ceasefire Relief Reversal BOK Holds: Oil Shock and Rates 1. Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Delhi has drafted EV Policy 2026–2030, replacing the 2020 framework, pivoting to scrappage-linked incentives, capping subsidies to mass-market vehicles below Rs 25 lakh, and targeting 36,000 charging points by 2030. With 90 lakh registered vehicles and India's most polluted urban air, Delhi's demand signal carries outsized influence on OEM product roadmaps, capex cycles, and localization timelines through 2030. Legacy OEMs with established service networks (TVS, Bajaj, Hero, Tata Motors, Ashok Leyland) stand to capture disproportionate benefits; pure-play EV startups without scale face a harder road ahead. 2.
cityfalcon.com
Brief India: Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? and more
In this briefing: Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth Primer: Nava (NAVA IN) - Apr 2026 Primer: Jubilant Foodworks (JUBI IN) - Apr 2026 Primer: Aegis Vopak Terminals (AEGISVOP IN) - Apr 2026 1. Delhi's EV Draft Policy: Who Wins the Policy Windfall of 2026–2030? Delhi has drafted EV Policy 2026–2030, replacing the 2020 framework, pivoting to scrappage-linked incentives, capping subsidies to mass-market vehicles below Rs 25 lakh, and targeting 36,000 charging points by 2030. With 90 lakh registered vehicles and India's most polluted urban air, Delhi's demand signal carries outsized influence on OEM product roadmaps, capex cycles, and localization timelines through 2030. Legacy OEMs with established service networks (TVS, Bajaj, Hero, Tata Motors, Ashok Leyland) stand to capture disproportionate benefits; pure-play EV startups without scale face a harder road ahead. 2. Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth With a potential $6 bn TAM by 2030, the Indian geospatial industry is shifting from simple maps to mission-critical infrastructure for governance, e-commerce, logistics, and autonomous mobility.
cityfalcon.com
Brief India: Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth and more
In this briefing: Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth Primer: Nava (NAVA IN) - Apr 2026 Primer: Jubilant Foodworks (JUBI IN) - Apr 2026 Primer: Aegis Vopak Terminals (AEGISVOP IN) - Apr 2026 Primer: Aegis Logistics (AGIS IN) - Apr 2026 1. Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth With a potential $6 bn TAM by 2030, the Indian geospatial industry is shifting from simple maps to mission-critical infrastructure for governance, e-commerce, logistics, and autonomous mobility. Genesys International dominates the high-accuracy engineering Digital-Twins/municipal infra projects with a strong track record and heavy initial investment, while MapmyIndia owns the high-volume consumer/automotive segment with its scalable SaaS ecosystem. We favor MapmyIndia for its recurring revenue model, leadership in private enterprise space and superior ROE stemming from relatively lower reliance on government contracts compared to Genesys’s capital-intensive, project-based business. 2.
cityfalcon.com
Brief Multi-Strategy: Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth and more
In this briefing: Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth Hong Kong Single Stock Options Weekly (Apr 08–10): Markets Awaken on the Back of Midweek Taco Rally HEW: Ceasefire Relief Reversal BOK Holds: Oil Shock and Rates The Stocks to Own in ASEAN – Vol. 54 1. Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth With a potential $6 bn TAM by 2030, the Indian geospatial industry is shifting from simple maps to mission-critical infrastructure for governance, e-commerce, logistics, and autonomous mobility. Genesys International dominates the high-accuracy engineering Digital-Twins/municipal infra projects with a strong track record and heavy initial investment, while MapmyIndia owns the high-volume consumer/automotive segment with its scalable SaaS ecosystem. We favor MapmyIndia for its recurring revenue model, leadership in private enterprise space and superior ROE stemming from relatively lower reliance on government contracts compared to Genesys’s capital-intensive, project-based business. 2.
cityfalcon.com
Smartkarma | Indian Geospatial: Why MapmyIndia’s Platform Beats Genesys’s Project-Led Growth
» Smartkarma / by Himanshu Dugar / Thematic (Sector/Industry) With a potential $6 bn TAM by 2030, the Indian geospatial industry is shifting from simple maps to mission-critical infrastructure for governance, e-commerce, logistics, and autonomous mobility. Genesys International dominates the high-accuracy engineering Digital-Twins/municipal infra projects with a strong track record and heavy initial investment, while MapmyIndia owns the high-volume consumer/automotive segment with its scalable SaaS ecosystem. We favor MapmyIndia for its recurring revenue model, leadership in private enterprise space and superior ROE stemming from relatively lower reliance on government contracts compared to Genesys’s capital-intensive, project-based business. » Get straight to the source on Smartkarma.
cityfalcon.com

Advertisement|Remove ads.